These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30285275)

  • 1. A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam.
    Tolbert D; Larsen F
    J Clin Pharmacol; 2019 Jan; 59(1):7-19. PubMed ID: 30285275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Drug Interactions on Clobazam and N-Desmethylclobazam Concentrations in Pediatric Patients With Epilepsy.
    Russell GR; Phelps SJ; Shelton CM; Wheless JW
    Ther Drug Monit; 2018 Aug; 40(4):452-462. PubMed ID: 29746397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions.
    Tolbert D; Bekersky I; Chu HM; Ette EI
    J Clin Pharmacol; 2016 Mar; 56(3):365-74. PubMed ID: 26224203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.
    VanLandingham KE; Crockett J; Taylor L; Morrison G
    J Clin Pharmacol; 2020 Oct; 60(10):1304-1313. PubMed ID: 32652616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Thorough QT/QTc Study of Clobazam in Healthy Volunteers.
    Tolbert D; Gordon J; Harris S; Walzer M; Bekersky I; Reid S
    Clin Ther; 2017 Oct; 39(10):2073-2086. PubMed ID: 28958437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics.
    Tolbert D; Bekersky I; Chu HM; Ette EI
    J Clin Pharmacol; 2016 Feb; 56(2):213-22. PubMed ID: 26139309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 10. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
    Bialer M; Perucca E
    Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
    Jullien V; Chhun S; Rey E; Dulac O; Tod M; Chiron C; Pons G
    Clin Pharmacokinet; 2015 May; 54(5):527-36. PubMed ID: 25503589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy.
    Saruwatari J; Ogusu N; Shimomasuda M; Nakashima H; Seo T; Tanikawa K; Tsuda Y; Nishimura M; Nagata R; Yasui-Furukori N; Kaneko S; Ishitsu T; Nakagawa K
    Ther Drug Monit; 2014 Jun; 36(3):302-9. PubMed ID: 24345815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL; Absalom NL; Abelev SV; Low IK; Doohan PT; Martin LJ; Chebib M; McGregor IS; Arnold JC
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.
    Contin M; Sangiorgi S; Riva R; Parmeggiani A; Albani F; Baruzzi A
    Ther Drug Monit; 2002 Dec; 24(6):737-41. PubMed ID: 12451290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.
    de Leon J; Spina E; Diaz FJ
    Ther Drug Monit; 2013 Feb; 35(1):30-47. PubMed ID: 23318278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome.
    Tolbert D; Chu HM; Ette EI
    Epilepsy Res; 2019 Nov; 157():106182. PubMed ID: 31563030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of clobazam oral soluble film.
    Heller AH; Wargacki S; Jung C; Buan CV; Wyatt DJ; Schobel AM
    Epilepsia; 2018 Nov; 59(11):2153-2161. PubMed ID: 30357823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.
    Morrison G; Crockett J; Blakey G; Sommerville K
    Clin Pharmacol Drug Dev; 2019 Nov; 8(8):1009-1031. PubMed ID: 30791225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.